Insiders Updates
Oppenheimer analysts initates an Outperform rating for ARS Pharmaceuticals Inc (SPRY)
ARS Pharmaceuticals Inc’s recently made public that its Director Shawver Laura unloaded Company’s shares for reported $0.62 million on Feb
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.